Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Chapel Hill, North Carolina 27599


Purpose:

To determine the incidence and predictors of augmented renal clearance (ARC) in patients with hemorrhagic stroke.


Criteria:

Inclusion Criteria: - Adults ≥ 18 years - Patients with hemorrhagic stroke - Anticipated length of stay in the neuroscience intensive care unit > 48 hours - Informed consent provided by the patient or by the patient's designated medical proxy Exclusion Criteria: - Pregnancy - Patients with pre-existing renal dysfunction (chronic kidney disease stages 3 - 5) - Patients receiving renal replacement therapy - Patients with an admission serum creatinine > 1.4 mg/dL - Patients with non-aneurysmal subarachnoid hemorrhage - Patients with history of nephrectomy or body mass index < 18 kg/m2


NCT ID:

NCT02386202


Primary Contact:

Principal Investigator
Kathryn A Morbitzer, PharmD
UNC Eshelman School of Pharmacy


Backup Contact:

N/A


Location Contact:

Chapel Hill, North Carolina 27599
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 22, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.